FDA Clearance Tracker · P980022-S013
PARADIGM REAL TIME SYSTEM
Last checked: Nov 20, 2026Latest source record: Apr 7, 2006 (this decision)Source: openFDAMethods & limitations
Decided
Apr 7, 2006
Approved
Time to decision
185 days
Received Oct 4, 2005. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P980022-S013
- Device name
- PARADIGM REAL TIME SYSTEM
- Applicant
- Medtronic Minimed
- Applicant location
- Northridge, CA
- Received
- Oct 4, 2005
- Decided
- Apr 7, 2006
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P980022
Device type
- Device type
- Sensor, glucose, invasive (MDS)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR MODIFICATIONS TO THE MMT 515/715 EXTERNAL INSULIN PUMP AND TO THE GUARDIAN RT SENSOR TO ENABLE THE PUMP TO ACCEPT DATA FROM THE SENSOR, AND TO ENABLE THE SENSOR TO COMMUNICATE DIRECTLY TO THE PUMP. THE DEVICE WILL BE MANUFACTURED AT MEDTRONIC MINIMED, NORTHRIDGE, CALIFORNIA.
Source documents
Other decisions for Medtronic Minimed
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261962 · Decided Jul 9, 2026 · 28 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.